- Home
- Applications
- north america
- tissue imaging
Refine by
Tissue Imaging Product Applications In North America
5 applications found
In vivo soft tissue imaging for morphological characterization. 2D and 3D imaging can be performed quickly and easily for preclinical model ...
ByAspect Imaging Ltd. based in Nashville, TENNESSEE (USA)
The advent of portable, point-of-care MR imaging forces full reconsideration of diagnostic and patient management possibilities much like portable X-ray and point-of-care ultrasound (POCUS) before it. The mental calculus of resources versus patient management has been rebalanced, giving clinicians routine, practical, frontline access to the sensitivity and specificity of MR soft tissue ...
ByHyperfine based in Guilford, CONNECTICUT (USA)
A critical factor in ensuring complete resection of a solid cancer tumor is the ability to determine where diseased tissue ends and healthy tissue begins. Our research, as well as our clinical collaborators, confirm that there is a pressing unmet clinical need: the ability to rapidly and globally assess the status of marginal tissue adjacent to a tumor while the patient is in the ...
ByAkrotome Imaging, Inc. based in Cleveland, OHIO (USA)
Standard Biopsy Limitations Traditionally, men suspected of prostate cancer undergo systematic biopsies guided by ultrasound imaging. Because ultrasound offers poor cancer visualization, 12 random samples are taken without knowing if there is cancer and if so, where it is. As a result, the cancer is either missed entirely, or if detected, is difficult to determine the extent and severity. This leads to under treatment of men with serious disease and overtreatment of men with indolent disease.4 ...
ByFocal Healthcare based in Toronto, ONTARIO (CANADA)
Advances in diagnostic methods have enabled the detection of cancer at the earliest stages when the chances for successful intervention are highest. For many solid tumors, the best chance for a cure is surgery. A surgical cure depends upon the complete removal of all cancer tissue from a patient (a “complete resection”). The main challenge of this approach is that it is very difficult for a surgeon to determine where diseased tissue ends and healthy tissue begins. The result is that many surgical ...
ByAkrotome Imaging, Inc. based in Cleveland, OHIO (USA)